Insufficient funds <a href=" http://www.irvinleisure.co.uk/when-will-nexium-become-generic.pdf ">nexium mups 20 mg</a> The six &ldquo;sizeable&rdquo; drugs on which Glaxo has pinned its near-term growth hopes have made important strides this year. Breo, GSK&rsquo;s new treatment for respiratory disease COPD, and skin cancer drugs Tafinlar and Mekinist, all won regulatory approval in the US in recent weeks. GSK expects the remaining three to get the green light by the end of the year.